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Background
Calcium governs a wide range of cellular processes.
Specifically, control of gene transcription involves Ca2+
entry channels that are activated by either voltage, sec-
ond messengers or depletion of intracellular stores.
The family of classical transient receptor potential
channels (TRPC) has been implicated in both the
receptor/second messenger as well as in store-operated
Ca2+ entry pathway, and represents an attractive target
for therapeutic intervention.
Methods
We tested a series of pyrazol compound structurally
related to Pyr3 [1], a recently discovered TRPC3 inhibi-
tor, for effects on receptor- as well as store-operated
Ca2+ entry into RBL-2H3 mast cells and HEK293 cells
overexpressing TRPC3.
Results and conclusions
We identified novel Ca2+ entry inhibitors, which are
able to discriminate between the two tightly related
pathways of receptor/second messenger-activated and
store-operated calcium entry. These compounds appear
suitable for selective modulation of Ca2+-dependent
gene transcription in a variety of mammalian cells.
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